11 funds
Funds
Risk Indica­tor
Net Asset Value
1 Year
3 Years
5 Years
10 Years
Equity strategies (11)
Equity strategiesCarmignac Investissement
FR0010148981
Global marketSRI Fund Article 8
Risk Indica­tor
4/7
Net Asset Value
2297.33 €22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 29.3 %
3 Years
+ 40.2 %
5 Years
+ 68.4 %
10 Years
+ 94.2 %
Equity strategiesCarmignac Portfolio Investissement
LU1299311677
Global marketSRI Fund Article 8
Risk Indica­tor
4/7
Net Asset Value
238.45 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 30.3 %
3 Years
+ 49.0 %
5 Years
+ 84.4 %
10 Years
-
Equity strategiesCarmignac Portfolio Grandchildren
LU1966631001
Global marketSRI Fund Article 9
Risk Indica­tor
4/7
Net Asset Value
211.97 €22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 23.0 %
3 Years
+ 33.1 %
5 Years
+ 73.8 %
10 Years
-
Equity strategiesCarmignac Emergents
FR0010149302
Emerging marketsSRI Fund Article 9
Risk Indica­tor
4/7
Net Asset Value
1237.55 €22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 14.5 %
3 Years
+ 2.4 %
5 Years
+ 21.3 %
10 Years
+ 50.6 %
Equity strategiesCarmignac Portfolio Emergents
LU1299303575
Emerging marketsSRI Fund Article 9
Risk Indica­tor
4/7
Net Asset Value
171.60 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 16.3 %
3 Years
+ 7.7 %
5 Years
+ 28.7 %
10 Years
-
Equity strategiesCarmignac Portfolio Asia Discovery
LU0807689582
Emerging marketsSRI Fund Article 8
Risk Indica­tor
4/7
Net Asset Value
219.40 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 23.9 %
3 Years
+ 19.1 %
5 Years
+ 38.6 %
10 Years
+ 80.9 %
Equity strategiesCarmignac Portfolio China New Economy
LU2427321034
Emerging marketsSRI Fund Article 8
Risk Indica­tor
6/7
Net Asset Value
64.16 $27/11/2024
Cumulative performance at 22/01/2025
1 Year
- 11.4 %
3 Years
-
5 Years
-
10 Years
-
Equity strategiesCarmignac Portfolio Grande Europe
LU0807689079
European marketSRI Fund Article 9
Risk Indica­tor
4/7
Net Asset Value
299.50 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 19.6 %
3 Years
+ 27.6 %
5 Years
+ 58.4 %
10 Years
+ 138.7 %
Equity strategiesCarmignac Portfolio Climate Transition
LU0807690754
ThematicESG Thematic Fund Article 8
Risk Indica­tor
5/7
Net Asset Value
110.77 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 6.2 %
3 Years
- 5.8 %
5 Years
+ 6.4 %
10 Years
+ 11.8 %
Equity strategiesCarmignac Portfolio Human Xperience
LU2295992163
ThematicESG Thematic Fund Article 9
Risk Indica­tor
4/7
Net Asset Value
137.49 €22/01/2025
Cumulative performance at 22/01/2025
1 Year
+ 18.5 %
3 Years
+ 28.4 %
5 Years
-
10 Years
-
Equity strategiesCarmignac Portfolio Tech Solutions
LU2809794493
ThematicSRI Fund Article 9
Risk Indica­tor
5/7
Net Asset Value
109.66 $22/01/2025
Cumulative performance at 22/01/2025
1 Year
-
3 Years
-
5 Years
-
10 Years
-

Legal Information

The information presented above is not contractually binding and does not constitute investment advice. Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without prior notice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (Key Information Documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase. The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.